Published on:

Failure To Diagnose Preeclampsia Decreases Through Use Of Biomarkers

Preeclampsia is a pregnancy complication affecting 10% of women. It is marked by high blood pressure and proteinuria (protein in the urine). Symptoms usually emerge in the 20th week of pregnancy, and include: headaches, hand and foot swelling (edema), excessive weight gain and, in extreme cases, blindness.

Preeclampsia must be timely diagnosed, because if left undiagnosed it can develop into eclampsia. Eclampsia can cause seizures, brain damage and death (for mother and child). Worldwide, preeclampsia is responsible for 500,000 infant deaths and 76,000 maternal deaths every year.

According to a recent study conducted by scientists at the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institute of Health, there may be a connection between maternal plasma concentrations and the risk for developing preeclampsia. The relationship between maternal plasma and preeclampsia should lead to a decrease in medical malpractice due to the late diagnosis of preeclampsia, as doctors will be able to screen for a patient’s predisposition to develop the dangerous condition.

The trial lawyers at Bottar Law, PLLC, have decades of experience investigating, prosecuting and trying to verdict all types of medical malpractice cases, including those concerning preeclampsia If you or a loved one recently been diagnosed with preeclampsia or eclampsia, you and/or your family may be entitled to compensation for lifelong health care, medical expenses, medical bills, loss of income, and pain and suffering.

To discuss your case or concerns with an experienced Central New York medical malpractice lawyer, contact Bottar Law, PLLC now at (315) 422-3466, (800) 336-LAWS, or by e-mail at

Contact Information